Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Share this content:
Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Ferring Pharmaceuticals

Contact
Dana Rathkopf, MD
646-422-4379

Karim Touijer, MD
646-422-4486

Principal Investigator
Dana Rathkopf, MD, Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT01542021

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters